Browsing Category

63951 posts
HOUSE OF ROSE PROFESSIONAL ANNOUNCES 2024 BREAK THE CEILING TOUCH THE SKY® WORLD TOUR

HOUSE OF ROSE PROFESSIONAL ANNOUNCES 2024 BREAK THE CEILING TOUCH THE SKY® WORLD TOUR

NEW YORK, Jan. 24, 2024 /PRNewswire/ — House of Rose Professional Pte…
ŸNSECT GRANTED FIRST APPROVAL OF ITS KIND, TO COMMERCIALISE MEALWORM PROTEINS FOR DOG FOOD IN THE USA

ŸNSECT GRANTED FIRST APPROVAL OF ITS KIND, TO COMMERCIALISE MEALWORM PROTEINS FOR DOG FOOD IN THE USA

PARIS, Jan. 24, 2024 /PRNewswire/ — Ÿnsect, one of the strongest players…
Pavlov Media Acquires NetExperience to Accelerate Global Expansion of Telecom Infra Project (TIP) OpenWiFi Solution

Pavlov Media Acquires NetExperience to Accelerate Global Expansion of Telecom Infra Project (TIP) OpenWiFi Solution

Award-winning open and disaggregated Wi-Fi technology provides seamless connectivity for multifamily, hospitality,…
Open RAN Set to Capture 6-8% of Total RAN Market by End of 2024, Fueled by Initiatives from Fujitsu, Samsung, Rakuten Symphony, and Mavenir

Open RAN Set to Capture 6-8% of Total RAN Market by End of 2024, Fueled by Initiatives from Fujitsu, Samsung, Rakuten Symphony, and Mavenir

NEW YORK, Jan. 24, 2024 /PRNewswire/ — The growing competition in the…
WestGene Spearheads Oncology Breakthroughs at the 3rd mRNA-Based Therapeutics Summit

WestGene Spearheads Oncology Breakthroughs at the 3rd mRNA-Based Therapeutics Summit

CHENGDU, China, Jan. 24, 2024 /PRNewswire/ — Kicking off the New Year with…
Positive Xanamem® human PET study published in the Journal of Alzheimer's Disease demonstrating robust CNS[1] target enzyme occupancy

Positive Xanamem® human PET study published in the Journal of Alzheimer's Disease demonstrating robust CNS[1] target enzyme occupancy

The study confirms that Xanamem is a brain-penetrant inhibitor of the tissue…
Genome & Company Announces Positive Topline Results from Phase 2 Clinical Trial of Combination of GEN-001 and Bavencio® for the Treatment of Gastric Cancer Poster presented at ASCO GI

Genome & Company Announces Positive Topline Results from Phase 2 Clinical Trial of Combination of GEN-001 and Bavencio® for the Treatment of Gastric Cancer Poster presented at ASCO GI

Results showed partial response being confirmed in 7 out of 42 patients…
Luxury ecotourism in Saudi Arabia takes a major step forward with Zardun

Luxury ecotourism in Saudi Arabia takes a major step forward with Zardun

The latest announcement from the NEOM Board of Directors, Zardun has been…